Partnership with Molbio Diagnostics

This partnership shall pave way for using TimBre™ as a first line of defense followed by Truenat from Molbio to facilitate a robust TB screening & diagnostics strategy.

The collaboration has obtained test license from CDSCO, India & currently generating data for the marketing license purposes.

Partnership with big Pharma (undisclosed)

docturnal is actively partnering with global pharmaceutical companies to align TimBre™ with their respiratory product portfolio

Support from USISTEF (Indo-US Endowment grant – 2024)

docturnal has received a grant from USISTEF to develop solutions for Lung Cancer screening and differentiating bacterial & viral Pneumonia cough signatures. TimBre™ is being repurposed to rollout these solutions during 2025